SLSN

Business Context and Reporting Period

Company: Nanophase Technologies Corporation (Note: Metadata listed "SOLESENCE, INC." but filing text confirms Nanophase Technologies Corporation).

Reporting Period: Quarterly Report (Form 10-Q) for the period ended June 30, 2004.

Business Overview: Nanophase is a developer and commercial manufacturer of nanocrystalline materials used in personal care (sunscreens), abrasion-resistant applications, environmental catalysts, and polishing applications (semiconductors, hard disk drives). The company operates a single business segment with facilities in Illinois.

Key Financial Metrics

Cash Flow (Six Months Ended June 30, 2004):

• Net cash used in operating activities: $(1,209,448)
• Net cash used in investing activities: $(8,372,175)
• Net cash provided by financing activities: $10,092,363

Material Changes vs. Prior Period

• Revenue: Total revenue increased 18% year-over-year for the three months ended June 30, 2004 ($1.54M vs. $1.31M), driven by a 192% increase in "Other revenue" (technology development funding). However, for the six-month period, total revenue decreased 5% ($2.84M vs. $2.97M) due to a decline in product sales to a major customer (Rohm and Haas Electronic Materials).
• Profitability: Net loss improved slightly for the three-month period ($(1.45M) vs. $(1.56M)) and the six-month period ($(2.92M) vs. $(3.00M)).
• Liquidity: Cash and investments increased significantly from $4.96M at year-end 2003 to $13.79M at June 30, 2004, primarily due to a $10M equity investment from Altana Chemie in March 2004.
• Cost of Revenue: Decreased for the six-month period ($2.64M vs. $2.78M) due to lower volume and manufacturing efficiencies, though gross margins remain modest.

Guidance, Outlook, and Risks

Management Commentary & Outlook:

• Management expects revenue growth in the CMP (chemical-mechanical-planarization) and fine polishing markets to begin in 2005.
• Increased demand for sunscreen and personal care materials is expected in 2004 compared to 2003.
• The company anticipates continuing to incur losses through at least the end of 2004.
• Process improvements are targeted to increase reactor output by 20-30% and reduce labor costs by 25%.

Material Risks and Contingencies:

• Customer Concentration: Three customers (BASF, RHEM, C.I. Kasei) accounted for approximately 90% of revenue for the six months ended June 30, 2004. Loss of any major customer would materially harm operations.
• Supply Agreement Triggers: The agreement with BASF contains covenants that could trigger a mandatory transfer of technology and equipment if the company fails to meet earnings targets or if cash/investments fall below $2.0 million. Management believes current liquidity ($13.8M) avoids this trigger.
• Capital Needs: The company may need to raise additional capital in the future. Failure to do so could force a reduction in operations or trigger the BASF equipment transfer clause.
• Intellectual Property: A third-party request for re-examination of a key manufacturing patent (NanoArc Synthesis) is pending with the USPTO. Narrowing of claims could impair legal protection.

Investor Verification Checklist

• Liquidity Covenants: Verify that cash and investments remain above the $2.0 million threshold required by the BASF supply agreement to prevent a forced technology/equipment transfer.
• Customer Concentration: Monitor order volumes from the top three customers (BASF, RHEM, C.I. Kasei), which represent the vast majority of revenue.
• Patent Status: Track the outcome of the USPTO re-examination of Patent No. 6,669,823 B1 regarding the NanoArc Synthesis process.
• Capital Raising: Assess the status of the $15 million universal shelf registration and the potential exercise of warrants from the September 2003 private placement.
• Revenue Mix: Confirm the sustainability of "Other revenue" (technology development funding) versus core product sales, as product revenue declined in the six-month period.